Zydelig Approved for Three Types of Blood Cancer
by Scott Roberts, Jul 23, 2014 at 1:56 PM • FDA Approvals
But label warns drug may be toxic to liver
by Scott Roberts, Jul 23, 2014 at 1:56 PM • FDA Approvals
But label warns drug may be toxic to liver
by Scott Roberts, Jul 3, 2014 at 11:32 AM • FDA Approvals
When lymph nodes become cancerous
by Dennis Thompson, HealthDay Reporter, Jun 4, 2014 at 9:00 AM • News
Researchers found screening, treatments weren't as good as patients with private insurance
by Amy Norton, HealthDay Reporter, Mar 12, 2014 at 5:00 PM • News
Idelalisib is being fast-tracked for FDA approval for use in patients with chronic lymphocytic leukemia
by HealthDay staff, Dec 9, 2013 at 7:00 AM • News
In many patients in early trials, turning T-cells into cancer fighters sent disease into remission
by Robert Preidt, Dec 4, 2013 at 12:00 PM • News
Researchers say hormones might play role in link, but don't know why
by Scott Roberts, Nov 13, 2013 at 3:47 PM • FDA Approvals
A rare blood cancer
by Amy Norton, HealthDay Reporter, Nov 7, 2013 at 9:00 AM • News
Better funding is vital to improve treatments, experts say
by Robert Preidt, Oct 31, 2013 at 9:00 AM • News
Study found increased survival rate but only for those with highest-risk disease
by Kathleen Doheny, HealthDay Reporter, Sep 17, 2013 at 9:00 AM • News
Millions more survive today, and experts say science is paying off
by Robert Preidt, Aug 28, 2013 at 9:00 AM • News
Chemo, radiation doses to the stomach found to raise odds
by Robert Preidt, Aug 5, 2013 at 5:00 PM • News
Blood cancer more common for those with continuing intestinal damage, study found
by Robert Preidt, Jul 29, 2013 at 9:00 AM • News
Benzene appears to raise risk of non-Hodgkin lymphoma, researchers say
by Robert Preidt, Jul 26, 2013 at 4:00 PM • News
Researchers found higher risk of death for those who had antiretroviral therapy
by Mary Elizabeth Dallas, Apr 10, 2013 at 5:00 PM • News
Approach resulted in high remission rates without the risks tied to radiotherapy, researchers say
Get the latest health news & tips via email, Mon‑Fri: